Eisenbach L - Search Results

1

Interleukin-6: effects on tumor models in mice and on the cellular regulation of transcription factor IRF-1.

Revel M, Katz A, Eisenbach L, Feldman M, Haran-Ghera N, Harroch S, Chebath J. Revel M, et al. Among authors: eisenbach l. Ann N Y Acad Sci. 1995 Jul 21;762:342-55; discussion 355-6. doi: 10.1111/j.1749-6632.1995.tb32338.x. Ann N Y Acad Sci. 1995. PMID: 7545371 No abstract available.

2

The use of [35S]methionine as a target cell label in long term cytotoxic assays.

Katz A, Feldman M, Eisenbach L. Katz A, et al. Among authors: eisenbach l. J Immunol Methods. 1992 May 18;149(2):255-60. doi: 10.1016/0022-1759(92)90257-t. J Immunol Methods. 1992. PMID: 1593137

3

Interleukin 6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells.

Porgador A, Tzehoval E, Katz A, Vadai E, Revel M, Feldman M, Eisenbach L. Porgador A, et al. Among authors: eisenbach l. Cancer Res. 1992 Jul 1;52(13):3679-86. Cancer Res. 1992. PMID: 1617640

4

MHC class I genes controlling the metastatic phenotype of tumor cells.

Feldman M, Eisenbach L. Feldman M, et al. Among authors: eisenbach l. Semin Cancer Biol. 1991 Oct;2(5):337-46. Semin Cancer Biol. 1991. PMID: 1773049 Review.

5

Tumor cell surface determinants in host immunity against metastases.

Eisenbach L, Feldman M. Eisenbach L, et al. Semin Cancer Biol. 1991 Jun;2(3):179-88. Semin Cancer Biol. 1991. PMID: 1912526 Review.

6

What makes a tumor cell metastatic?

Feldman M, Eisenbach L. Feldman M, et al. Among authors: eisenbach l. Sci Am. 1988 Nov;259(5):60-5, 68, 85. doi: 10.1038/scientificamerican1188-60. Sci Am. 1988. PMID: 2463669 No abstract available.

7

Reversal of the metastatic phenotype in Lewis lung carcinoma cells after transfection with syngeneic H-2Kb gene.

Plaksin D, Gelber C, Feldman M, Eisenbach L. Plaksin D, et al. Among authors: eisenbach l. Proc Natl Acad Sci U S A. 1988 Jun;85(12):4463-7. doi: 10.1073/pnas.85.12.4463. Proc Natl Acad Sci U S A. 1988. PMID: 3380801 Free PMC article.

8

Abrogation of B16 melanoma metastases by long-term low-dose interleukin-6 therapy.

Katz A, Shulman LM, Porgador A, Revel M, Feldman M, Eisenbach L. Katz A, et al. Among authors: eisenbach l. J Immunother Emphasis Tumor Immunol. 1993 Feb;13(2):98-109. doi: 10.1097/00002371-199302000-00004. J Immunother Emphasis Tumor Immunol. 1993. PMID: 8318501

9

Combined therapy with IL-6 and inactivated tumor cells suppresses metastasis in mice bearing 3LL lung carcinomas.

Katz A, Shulman LM, Revel M, Feldman M, Eisenbach L. Katz A, et al. Among authors: eisenbach l. Int J Cancer. 1993 Mar 12;53(5):812-8. doi: 10.1002/ijc.2910530518. Int J Cancer. 1993. PMID: 8449606

10

Unmasking by soluble IL-6 receptor of IL-6 effect on metastatic melanoma: growth inhibition and differentiation of B16-F10.9 tumor cells.

Oh JW, Katz A, Harroch S, Eisenbach L, Revel M, Chebath J. Oh JW, et al. Among authors: eisenbach l. Oncogene. 1997 Jul 31;15(5):569-77. doi: 10.1038/sj.onc.1201213. Oncogene. 1997. PMID: 9247310

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters